Literature DB >> 27162841

Profound Bradycardia following Patent Ductus Arteriosus Closure; A Rare but Correctable Event.

Khalil Zarrabi1, Parsa Ravanfar1, Azimeh Azimifar1, Fariborz Ghaffarpasand2.   

Abstract

Proximity of the vagus nerve to  a patent  ductus  arteriosus (PDA) can cause traction  or  entrapment  of vagus nerve during surgical closure of the in rare occasions. This can lead to a life threatening postoperative bradycardia. Herein, we report a case of bradycardia caused by unexpected irritation of the vagal trunk by the end of operation. The patient was managed by re-opening the chest, lung retraction and removal of mediastinal pleura sutures. The vagal trunk entrapped in the suture line was released immediately. Heart rate accelerated and hemodynamic restored after a short period of observation. The operation terminated as routine, patient extubated in OR and discharged within 24 hours with no further complication. This irritation of vagus results in vagal bradycardia during or by the end of operation. Awareness of a surgeon of this issue can minimize the risks and complications of the open closure of PDA.

Entities:  

Keywords:  Congenital heart disease; Patent ductus arteriosus; Surgery; Vagal bradycardia

Year:  2013        PMID: 27162841      PMCID: PMC4779175     

Source DB:  PubMed          Journal:  Bull Emerg Trauma        ISSN: 2322-2522


  17 in total

1.  The incidence of congenital heart disease in children born in Gothenburg 1941-1950.

Authors:  L E CARLGREN
Journal:  Br Heart J       Date:  1959-01

Review 2.  Patent ductus arteriosus in the preterm infant: to treat or not to treat?

Authors:  S Noori
Journal:  J Perinatol       Date:  2010-10       Impact factor: 2.521

Review 3.  Patent ductus arteriosus.

Authors:  Douglas J Schneider; John W Moore
Journal:  Circulation       Date:  2006-10-24       Impact factor: 29.690

4.  Cost-effectiveness of transaxillary muscle-sparing same-day operative closure of patent ductus arteriosus.

Authors:  F Cetta; S Y Deleon; P T Roughneen; L C Graham; R C Lichtenberg; T J Bell; D A Vitullo; E A Fisher
Journal:  Am J Cardiol       Date:  1997-05-01       Impact factor: 2.778

5.  Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment.

Authors:  Nami Jhaveri; Anita Moon-Grady; Ronald I Clyman
Journal:  J Pediatr       Date:  2010-09       Impact factor: 4.406

6.  Patent ductus arteriosus in adults--long-term follow-up: nonsurgical versus surgical treatment.

Authors:  R G Fisher; D S Moodie; R Sterba; C C Gill
Journal:  J Am Coll Cardiol       Date:  1986-08       Impact factor: 24.094

7.  Congenital heart disease in 56,109 births. Incidence and natural history.

Authors:  S C Mitchell; S B Korones; H W Berendes
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

8.  Cost and efficacy of surgical ligation versus transcatheter coil occlusion of patent ductus arteriosus.

Authors:  J A Hawkins; L L Minich; L Y Tani; J E Sturtevant; G S Orsmond; E C McGough
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

9.  ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease).

Authors:  Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb
Journal:  Circulation       Date:  2008-11-07       Impact factor: 29.690

Review 10.  Forty-six years of patient ductus arteriosus division at Children's Memorial Hospital of Chicago. Standards for comparison.

Authors:  C Mavroudis; C L Backer; M Gevitz
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.